COHLHEPP RYAN (President and COO) sold 6.1% of their position (12.50K shares) of BICARA THERAPEUTICS INC. on the open market
Open‑market sale worth $253.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/18/2026ACC: 0001628280-26-035937
DirectorOfficer· President and COO
Since Mar 2026
-12.50K
Net shares
Net seller
$253.6K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
8K acquired · 20.50K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+8K
Price / share
$3.79
Trade value
$30.32K
% of position
4.1%
5/15/2026
196.14K→204.14K
Common Stock
Direct
Shares
−8K
Price / share
$20.29
Trade value
$162.34K
% of position
3.9%
5/15/2026
204.14K→196.14K
Common Stock
Direct
Shares
−4.50K
Price / share
$20.29
Trade value
$91.31K
% of position
2.3%
5/15/2026
196.14K→191.64K
Total
Net shares
−4.50K
Net value
-$223.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2026 | M · Option Exercise | +8K | $3.79 | $30.32K | 4.1% | 196.14K | 204.14K |
| Common Stock Direct | 5/15/2026 | S · Sale | −8K | $20.29 | $162.34K | 3.9% | 204.14K | 196.14K |
| Common Stock Direct | 5/15/2026 | S · Sale | −4.50K | $20.29 | $91.31K | 2.3% | 196.14K | 191.64K |
| Total | −4.50K | -$223.33K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
8K shares
Shares
−8K
Strike price
3.7898
Held after
101.33K
Exercisable
—
5/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock8K shares | 5/15/2026 | M · Option Exercise | −8K | 3.7898 | — | 101.33K |